Apellis Pharmaceuticals, Inc.
APLSNASDAQHealthcare
$41.03
+$0.00(+0.00%)
Market Cap$5.3B
P/E Ratio—
52W High$41.14
52W Low$16.61
Apellis Pharmaceuticals, Inc.（APLS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · APLS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.00B | $0.78B | $0.40B | $0.08B | $0.07B |
| Cost of Revenue | $0.10B | $0.12B | $0.06B | $0.01B | $0.01B |
| Gross Profit | $0.90B | $0.66B | $0.34B | $0.07B | $0.06B |
| Gross Margin %(computed) | 89.81% | 84.93% | 85.25% | 92.53% | 92.19% |
| Operating Expenses | |||||
| R&D Expenses | $0.30B | $0.33B | $0.35B | $0.39B | $0.42B |
| G&A Expenses | $0.00B | $0.42B | $0.50B | $0.28B | $0.18B |
| Total Operating Expenses | $0.85B | $0.83B | $0.86B | $0.66B | $0.60B |
| Operating Income | $0.06B | ($0.16B) | ($0.52B) | ($0.59B) | ($0.54B) |
| Operating Margin %(computed) | 5.52% | -21.11% | -130.39% | -788.38% | -805.67% |
| Interest Income | $0.01B | $0.01B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.04B | $0.04B | $0.03B | $0.03B | $0.01B |
| Income Before Tax | $0.02B | ($0.20B) | ($0.53B) | ($0.65B) | ($0.75B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.02B | ($0.20B) | ($0.53B) | ($0.65B) | ($0.75B) |
| Net Margin %(computed) | 2.23% | -25.32% | -133.29% | -864.70% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.18 | $-1.60 | $-4.45 | $-6.15 | $-8.84 |
| Wtd Avg Shares | 0.13B | 0.12B | 0.12B | 0.11B | 0.08B |
| EBITDA | $0.07B | ($0.15B) | ($0.50B) | ($0.62B) | ($0.73B) |
| EBITDA Margin %(computed) | 6.97% | -19.78% | -124.87% | -818.58% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Apellis Pharmaceuticals, Inc.
关于Apellis Pharmaceuticals, Inc.（APLS）损益表
Apellis Pharmaceuticals, Inc.（APLS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，APLS实现营收$1.00B，毛利润$0.90B（毛利率89.81%），净利润$0.02B（净利率2.23%）。
常见问题
APLS · 4 问Apellis Pharmaceuticals, Inc.（APLS）2025财年营收为$1.00B，同比up28.5%。
APLS revenueAPLS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08